{"id":20267490,"updated":"2026-06-15T14:52:21Z","additionalIndexing":"2841","affairType":{"abbreviation":"Fra.","id":14,"name":"Fragestunde. Frage"},"author":{"councillor":{"code":10838,"gender":"m","id":10838,"name":"Vontobel Erich","officialDenomination":"Vontobel"},"faction":{"abbreviation":"Fraktion V","code":"V","id":4,"name":"Fraktion der Schweizerischen Volkspartei"},"type":"author"},"deposit":{"council":{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N"},"date":"2026-06-08T00:00:00Z","legislativePeriod":52,"session":"5214"},"descriptors":[],"drafts":[{"consultation":{"resolutions":[{"category":{"id":3,"name":"Normal"},"council":{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N"},"date":"2026-06-15T00:00:00Z","text":"Mündliche Beantwortung der Frage","type":82}]},"federalCouncilProposal":{},"index":0,"links":[],"preConsultations":[],"references":[],"relatedDepartments":[{"abbreviation":"EDI","id":4,"name":"Departement des Innern","leading":true}],"states":[{"date":"\/Date(1780869600000+0200)\/","id":202,"name":"Eingereicht"},{"date":"\/Date(1781474400000+0200)\/","id":229,"name":"Erledigt"}],"texts":[]}],"language":"de","priorityCouncils":[{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N","priority":1}],"relatedAffairs":[],"roles":[{"councillor":{"code":10838,"gender":"m","id":10838,"name":"Vontobel Erich","officialDenomination":"Vontobel"},"faction":{"abbreviation":"Fraktion V","code":"V","id":4,"name":"Fraktion der Schweizerischen Volkspartei"},"type":"author"}],"shortId":"26.7490","state":{"id":229,"name":"Erledigt","doneKey":"0","newKey":1},"texts":[{"type":{"id":5,"name":"Eingereichter Text"},"value":"<p>1. Mit welchen Labormethoden kann untersucht werden, ob und gegebenenfalls in welchen Organen Spikeproteine nach einer mRNA-Impfung nachweisbar sind?<br>2. Wurden solche Untersuchungen während der Covid-19-Pandemie vorgenommen? Wenn ja, von welcher Behörde und sind die Berichte öffentlich zugänglich?<br>3. Gibt es Berichte der Impfstoffhersteller, wonach die Spikeproteine nur an der Einstichstelle und in den Lymphknoten verbleiben?<br>4. Wie kann ein möglicher Impfschaden labortechnisch festgestellt werden?<\/p>"},{"type":{"id":1,"name":"Titel des Geschäftes"},"value":"Nachweis und Verbleib von Spikeproteinen nach mRNA-Impfungen"}],"title":"Nachweis und Verbleib von Spikeproteinen nach mRNA-Impfungen"}